NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ostia Sciences Inc.

Ostia Sciences Inc.

Private
TorontoHealthcare & Life Scienceshttps://ostiasciences.ca/

Last Round

Seed

Jul 18, 2025

Total Funding Raised

$1.73M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ostia Sciences Inc. is a biotechnology company that develops innovative oral probiotics and biotherapeutics for improving global health outcomes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

microbiome therapeuticsprobioticsoral microbiomebiotherapeuticslantibioticdrug discoverybugs to drugsimmunomodulationlive biotherapeuticsoral healthdrug discovery platformrespiratory healthclinical trialsCDMO partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ostia Sciences Inc. Comparables

Compare Ostia Sciences Inc. with similar companies based on industry and business-model similarity.

Ostia Sciences Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DermBiont
80%
SciBac, Inc.
75%
Alveolus Bio
65%

Ostia Sciences Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 18, 2025
GrantDec 31, 2024

Key People

Founding team and executive leadership

Michael Glogauer

Co-Founder and Chief Scientific Officer

Founding Team

Abdelahhad Barbour

CEO Co-Founder

Founding Team

Ostia Sciences Inc. Investors

Notable investors and investment history

Ostia Sciences Inc. investors
InvestorRounds
Natural Products CanadaSeed, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Received hands-on support from Invest Ontario for provincial expansion.

  • Apr 20, 2026

    A new $12 million project will accelerate growth with new offices in Ontario, Canada.

Ostia Sciences Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ostia Sciences Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ostia Sciences Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range12
Year Founded2024
Last FundingJul 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.